Scientists around the world investigate how bat immune systems cope with viral attacks and how this information could be used to keep humans safe.

Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.

With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.

Self-contained synthetic E. coli resistant to viral infection could prove invaluable to the biotechnology industry by increasing product consistency and reducing safety concerns. 

p53 is possibly the most important protein for maintaining cellular function. Losing it is synonymous with cancer.

Once obscure mud microbes inspire a new generation of living electronics.

A study employing CRISPR/Cas9 to explore the evolutionary beginnings of some giant viruses finds evidence their large genomes arose from gene duplications.

Haydeh Payami helped uncover the genetic basis of Parkinson’s disease. Now, she hopes to find new ways to treat the disease by studying the gut microbiome.

Bioengineered bacteria sneak past solid tumor defenses to guide CAR T cells’ attacks.